Revenue: The sum of all revenue fields included for a company's operating activities.
Enzo Biochem, Inc. (ENZB) had Revenue of $7.33M for the most recently reported fiscal quarter, ending 2025-01-31.
Income Statement Financials | |
Revenue |
$7.33M |
$-1.53M |
|
$3.55M |
|
$3.79M |
|
$8.94M |
|
$-1.60M |
|
$0.35M |
|
$-1.25M |
|
$-1.25M |
|
$-1.25M |
|
$-1.25M |
|
$-1.53M |
|
$-1.25M |
|
$-1.60M |
|
$-1.28M |
|
52.30M |
|
52.30M |
|
$-0.03 |
|
$-0.03 |
|
Balance Sheet Financials | |
$52.22M |
|
$12.30M |
|
$15.29M |
|
$67.51M |
|
$17.18M |
|
$0.15M |
|
$3.72M |
|
$20.89M |
|
$46.62M |
|
$46.62M |
|
$46.62M |
|
52.40M |
|
Cash Flow Statement Financials | |
$-11.02M |
|
$4.48M |
|
$-5.52M |
|
$52.37M |
|
$40.30M |
|
$-12.07M |
|
$0.35M |
|
$-5.32M |
|
-- |
|
Fundamental Metrics & Ratios | |
3.04 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
51.61% |
|
-21.84% |
|
-21.84% |
|
-- |
|
-17.02% |
|
-20.93% |
|
$-11.53M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.59 |
|
1.73 |
|
52.09 |
|
-2.68% |
|
-2.68% |
|
-1.85% |
|
-2.67% |
|
$0.89 |
|
$-0.22 |
|
$-0.21 |